| # | Drug | Count |
|---|
| # | Drug | Count | Frequency |
|---|
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 125 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 115 |
| 2 | Platinum-based Drug [EPC] | 104 |
| 3 | Loop Diuretic [EPC] | 89 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 84 |
| 5 | Alkylating Drug [EPC] | 83 |
| 6 | Benzodiazepine [EPC] | 78 |
| 7 | Proton Pump Inhibitor [EPC] | 53 |
| 8 | Interferon beta [EPC] | 44 |
| 9 | beta-Adrenergic Blocker [EPC] | 44 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lymphocyte Growth Factor [EPC] | 4 | 0.0032 |
| 1 | CD33-directed Immunoconjugate [EPC] | 9 | 0.0025 |
| 2 | Tricyclic Antidepressant [EPC] | 1 | 0.0021 |
| 3 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 11 | 0.0015 |
| 4 | Interferon gamma [EPC] | 2 | 0.0014 |
| 5 | Epidermal Growth Factor Receptor Antagonist [EPC] | 41 | 0.0009 |
| 6 | Vitamin D2 Analog [EPC] | 6 | 0.0008 |
| 7 | Blood Viscosity Reducer [EPC] | 3 | 0.0007 |
| 8 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 6 | 0.0007 |
| 9 | Paramagnetic Contrast Agent [EPC] | 3 | 0.0007 |